medication management News
-
Pulmonx to Present at the Canaccord Genuity 42nd Annual Growth Conference
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Jul. 27, 2022-- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced the company will present at the upcoming Canaccord Genuity 42nd Annual Growth Conference in Boston. Management is scheduled to present on Wednesday, August 10, 2022, at 1:00 PM PT / 4:00 PM ET. ...
-
Pulmonx to Present at the 34th Annual Piper Sandler Healthcare Conference
Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for severe lung disease, today announced the company will be participating in a fireside chat at the 34th Annual Piper Sandler Healthcare Conference in New York on Wednesday, November 30, 2022, at 11:30 AM PT / 2:30 PM ET. A live and archived webcast of the presentation will be available ...
-
Pulmonx to Present at the Bank of America Securities 2022 Healthcare Conference
Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced the company will present at the upcoming Bank of America Securities 2022 Healthcare Conference in Las Vegas. Management is scheduled to present on Tuesday, May 10, 2022, at 12:40 PM PT / 3:40 PM ET. A live and archived webcast of the presentation ...
-
Pulmonx to Participate at Upcoming Investor Conferences
Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for severe lung disease, today announced the company will be participating in two upcoming investor conferences in New York. Pulmonx management is scheduled to participate in a fireside chat at the Stifel Healthcare Conference on Wednesday, November 16, 2022, at 8:00AM ET. Interested ...
-
Aresus announces change in the management
Aresus Pharma GmbH, a subsidiary of DERMAGO Verwaltungs GmbH, has announced today that Dr. Francisco Harrison left his position as Managing Director for personal reasons. Dr. Harrison was in charge of Aresus‘ medical-scientific division. Co-Managing Director, Mr. Sven Schimansky-Wabra, will be in charge of Aresus‘ business operations as sole Managing Director with immediate effect. ...
-
GI Dynamics Announces Approval of the I-STEP Clinical Study in India
BOSTON & HYDERABAD, India--( )-- GI Dynamics Inc., a medical device company that isBUSINESS WIRE developing the EndoBarrier® System for patients diagnosed with type 2 diabetes and obesity, is pleased to announce that it has received regulatory approval to begin enrollment in the I-STEP clinical trial in India. I-STEP is a multi-center, randomized, pivotal study evaluating the safety and ...
-
Lyra Therapeutics Announces Publication of Positive LANTERN Results in the International Forum of Allergy & Rhinology
Company to Initiate Phase 3 ENLIGHTEN Program around YE’21 Lyra Therapeutics, Inc. (Nasdaq: LYRA), a clinical-stage therapeutics company leveraging its proprietary XTreo™ platform to enable precise, sustained, and local delivery of medications to the ear, nose and throat (ENT) passages and other diseased tissues, today announced that the positive results of the Company’s Phase ...
-
Two ministries support the domestic medical equipment and will establish incentive mechanism
Recently, the National Health Commission and the Ministry of Industry jointly held the conference to promote the development and application of domestic medical equipment, the domestic medical equipment upgrades once again become the focus. Miao Wei, Minister of Industry and Information, said that in order to promote the development of domestic medical equipment industry, will establish the ...
-
Safe Label System now integrates with JVM’s automated anesthesia dispensing cabinet
Pharmacy and Hospital Automation Solution provider JVM became an Integrator of Codonics Safe Label System to deliver more complete anesthesia medication management solutions to operating rooms in hospitals worldwide. JVM, a subsidiary of Hanmi Pharmaceuticals and leading global provider of pharmacy and hospital automation solutions including ATDPS and INTIPharm, today announced its integrator ...
By Codonics
-
National Fire Academy Completes New Emergency Medical Services Courses
EMMITSBURG, MD - The U.S. Fire Administration's (USFA) National Fire Academy (NFA) has completed development of the first two new Emergency Medical Services (EMS) courses in response to the U.S. Fire Administration Reauthorization Act of 2008. An additional six courses are in the process of development or revision. The Reauthorization Act included direction for the National Fire Academy to ...
-
Hyalex Receives ISO 13485 Certification
We are happy to announce that Hyalex Orthopaedics has received ISO 13485:2016 certification for Medical Device and Quality Management Systems. This certification is a regulatory requirement and international standard outlining requirements for a medical device quality management system. It brings Hyalex one step closer to the clinic and patients who may benefit from the HYALEX Cartilage System. ...
-
Lyra Therapeutics to Highlight LYR-210 and LYR-220 Clinical Programs at Virtual Event with Leading Clinical CRS Experts
Lyra Therapeutics, Inc. (Nasdaq: LYRA), a clinical-stage therapeutics company leveraging its proprietary XTreo™ platform to enable precise, sustained, and local delivery of medications to the ear, nose and throat (ENT) passages and other diseased tissues will host a virtual event with leading chronic rhinosinusitis (CRS) experts to highlight the Company's LYR-210 and LYR-220 clinical ...
-
Lyra Therapeutics to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
Lyra Therapeutics, Inc. (Nasdaq: LYRA), a clinical-stage therapeutics company leveraging its proprietary XTreo™ platform to enable precise, sustained, and local delivery of medications to the ear, nose and throat (ENT) passages and other diseased tissues, today announced that Maria Palasis, Ph.D., Lyra’s President and Chief Executive Officer, will present in a virtual format at the ...
-
Brentwood Expands Manufacturing Capacity
Brentwood is proud to announce that it will open a medical manufacturing facility in Tijuana, Mexico, in early 2018. This second facility represents Brentwood’s first strategic international expansion dedicated to custom thermoformed medical packaging. As a major North American medical manufacturing hub, Tijuana continues to experience growth at a rapid pace. “We’ve been ...
-
TOMORROW: EPA Recognizes City of Dallas and Partners for Collaborating to Fight Asthma Triggers
Today, the U.S. Environmental Protection Agency (EPA) will recognize the City of Dallas and the Health and Wellness Alliance for Children for their collaboration to improve children’s health in the Dallas area. The groups are bringing together a variety of stakeholders to reduce environmental triggers for the 60,000 children in Dallas with asthma. Asthma is a serious, sometimes ...
-
Cardiac telerehabilitation system implemented in Przemysl, southeast of Poland
In times of pandemic, cardiac rehabilitation centres search for solutions which allow them to continue remote rehabilitation, while making it possible to maintain constant contact with the patient. This solution must provide possibility to assess the patient's condition before training, set training parameters adjusted to individual needs and must ensure easy access to records from rehabilitation ...
By Pro-PLUS SA
-
Congratulations to Dave Harry on his Swimathon 2015
It’s been a tough but very worthwhile swimming journey for our Wales and West Contracts Manager Dave Harry who recently took part in Swimathon 2015 fundraising for Ehlers-Danlos syndrome. Dave successfully swam 5KM (3 miles) and raised £455 towards ongoing research into this condition – a huge thank you to everyone that sponsored and supported Dave along the way including his ...
-
Lyra Therapeutics Announces Initiation Of Lyr-210 Pivotal Phase 3 Enlighten Program In Surgically Naïve Chronic Rhinosinusitis Patients
LYR-210 and LYR-220 are designed to complement each other in addressing the broad spectrum of CRS patients treated by ENT Physicians Lyra Therapeutics, Inc. (Nasdaq: LYRA), a clinical-stage therapeutics company leveraging its proprietary XTreo™ platform to enable precise, sustained, and local delivery of medications to the ear, nose and throat (ENT) passages and other diseased tissues, ...
-
Lyra Therapeutics to Present at Upcoming Virtual Investor Conferences
Lyra Therapeutics, Inc. (Nasdaq: LYRA), a clinical-stage therapeutics company leveraging its proprietary XTreo™ platform to enable precise, sustained, and local delivery of medications to the ear, nose and throat (ENT) passages and other diseased tissues, today announced that Maria Palasis, Ph.D., Lyra's President and Chief Executive Officer, will present in a virtual format at three ...
-
Clinical Data Presented at 2022 North American Neuromodulation Society (NANS) Annual Meeting Reinforce Significant and Durable Benefits of Nevro`s 10 kHz Therapy
SENZA-PDN Randomized Controlled Trial Results Demonstrate Significant and Sustained Outcomes with 10 kHz Therapy at 18-Months Follow-Up. SENZA-NSRBP Randomized Controlled Trial Results Show Profound Improvements in Non-Surgical Refractory Back Pain Patients Receiving 10 kHz Therapy Relative to Conventional Medical Management at 12-Months Follow-Up. Both SENZA-PDN and SENZA-NSRBP Studies ...
By Nevro Corp.
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you